HP1328 is a highly effective inhibitor of FLT3 receptor tyrosine kinase with a specific focus on FLT3/ITD mutation. It belongs to the benzoimidazole scaffold-based compound family. Significantly reducing the leukemia burden, HP1328 effectively extends the survival of mice afflicted with FLT3/ITD leukemia [1].
Molecular Weight:
389.45
CAS Number:
[2245074-20-6]
Formula:
C23H23N3O3
Target:
Others|||FLT
T61758
* VAT and and shipping costs not included. Errors and price changes excepted
